Lv629
2570 积分 2021-09-17 加入
Predicting and analyzing stability in perovskite solar cells: Insights from machine learning models and SHAP analysis
4天前
已完结
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial
8天前
已完结
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
8天前
已完结
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma
8天前
已完结
Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial
8天前
已完结
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma
8天前
已完结
New Mutation in TGFBR2 in a Female Newborn with Aortic Rupture
25天前
已关闭
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial
1个月前
已完结
Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial
1个月前
已完结
Heart rate changes in chronically red cell transfusion‐dependent patients—A dose‐dependent effect of red cell transfusion: A randomized cross‐over trial, interim analysis
1个月前
已完结
皖公网安备34019202002308
